These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17932658)

  • 1. In vivo detection of DNA adducts induced by cisplatin using capillary HPLC-ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster.
    García Sar D; Montes-Bayón M; Aguado Ortiz L; Blanco-González E; Sierra LM; Sanz-Medel A
    Anal Bioanal Chem; 2008 Jan; 390(1):37-44. PubMed ID: 17932658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between cisplatin-induced adducts and DNA strand-breaks, mutation and recombination in vivo in somatic cells of Drosophila melanogaster, under different conditions of nucleotide excision repair.
    García Sar D; Aguado L; Montes Bayón M; Comendador MA; Blanco González E; Sanz-Medel A; Sierra LM
    Mutat Res; 2012 Jan; 741(1-2):81-8. PubMed ID: 22108251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the complexity and dynamics of in vivo Cisplatin-DNA adduct formation using HPLC/ICP-MS.
    Ziehe M; Esteban-Fernández D; Hochkirch U; Thomale J; Linscheid MW
    Metallomics; 2012 Oct; 4(10):1098-104. PubMed ID: 22986644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
    Yamada K; Kato N; Takagi A; Koi M; Hemmi H
    Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative profiling of in vivo generated cisplatin-DNA adducts using different isotope dilution strategies.
    García Sar D; Montes-Bayón M; Blanco González E; Sierra LM; Aguado L; Comendador MA; Koellensperger G; Hann S; Sanz-Medel A
    Anal Chem; 2009 Dec; 81(23):9553-60. PubMed ID: 19886652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.
    Baskerville-Abraham IM; Boysen G; Troutman JM; Mutlu E; Collins L; Dekrafft KE; Lin W; King C; Chaney SG; Swenberg JA
    Chem Res Toxicol; 2009 May; 22(5):905-12. PubMed ID: 19323581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized sample preparation strategy for the analysis of low molecular mass adducts of a fluorescent cisplatin analogue in cancer cell lines by CE-dual-LIF.
    Zabel R; Kullmann M; Kalayda GV; Jaehde U; Weber G
    Electrophoresis; 2015 Feb; 36(4):509-17. PubMed ID: 25483804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
    Farmer PB; Singh R
    Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
    Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
    Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of DNA adducts using liquid chromatography/electrospray ionization mass spectrometry and liquid chromatography/high-resolution inductively coupled plasma mass spectrometry.
    Siethoff C; Feldmann I; Jakubowski N; Linscheid M
    J Mass Spectrom; 1999 Apr; 34(4):421-6. PubMed ID: 10226366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry of cis-diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap.
    Hagemeister T; Linscheid M
    J Mass Spectrom; 2002 Jul; 37(7):731-47. PubMed ID: 12125006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA.
    Meczes EL; Azim-Araghi A; Ottley CJ; Pearson DG; Tilby MJ
    Biochem Pharmacol; 2005 Dec; 70(12):1717-25. PubMed ID: 16259963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of cisplatin-induced nephrotoxicity in vivo by selenomethionine: the effect on cisplatin-DNA adducts.
    García Sar D; Montes-Bayón M; Blanco González E; Sierra Zapico LM; Sanz-Medel A
    Chem Res Toxicol; 2011 Jun; 24(6):896-904. PubMed ID: 21491944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin.
    Brouwers EE; Tibben MM; Pluim D; Rosing H; Boot H; Cats A; Schellens JH; Beijnen JH
    Anal Bioanal Chem; 2008 May; 391(2):577-85. PubMed ID: 18385987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of DNA adduct, S-[2-(N7-guanyl)ethyl]glutathione, by liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry.
    Huang H; Jemal A; David C; Barker SA; Swenson DH; Means JC
    Anal Biochem; 1998 Dec; 265(1):139-50. PubMed ID: 9866718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of melphalan DNA adducts using HPLC - inductively coupled mass spectrometry.
    Edler M; Jakubowski N; Linscheid M
    J Mass Spectrom; 2006 Apr; 41(4):507-16. PubMed ID: 16541389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs.
    Corte-Rodríguez M; Espina M; Sierra LM; Blanco E; Ames T; Montes-Bayón M; Sanz-Medel A
    Biochem Pharmacol; 2015 Nov; 98(1):69-77. PubMed ID: 26352094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes.
    Jones CR; Sabbioni G
    Chem Res Toxicol; 2003 Oct; 16(10):1251-63. PubMed ID: 14565767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.